Cyclin D1 Recombinant Rabbit Monoclonal Antibody [SA38-08]
Usd: 385 Special Discount
Specification
Catalog# ET1601-31
Cyclin D1 Recombinant Rabbit Monoclonal Antibody [SA38-08]
-
WB
-
IF-Cell
-
IF-Tissue
-
IHC-P
-
IP
-
FC
-
Human
-
Mouse
-
Rat
-
unconjugated
Safety datasheet
Overview
Product Name
Cyclin D1 Recombinant Rabbit Monoclonal Antibody [SA38-08]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within C-terminal human Cyclin D1.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, IP, FC
Molecular Weight
Predicted band size: 34 kDa
Positive Control
MCF7 cell lysate, K-562 cell lysate, A431 cell lysate, Neuro-2a cell lysate, NIH/3T3 cell lysate, C6 cell lysate, SH-SY5Y cell lysate, Neuro-2a, MCF7, human tonsil tissue, human colon carcinoma tissue, human liver carcinoma tissue, human small intestine tissue.
Conjugation
unconjugated
Clone Number
SA38-08
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:5,000
-
IF-Cell
-
1:2,000
-
IF-Tissue
-
1:500
-
IHC-P
-
1:200-1:1,000
-
IP
-
Use at an assay dependent concentration.
-
FC
-
1:5,000
Target
Function
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDKs (Cyclin-dependent kinase). Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. Micrograph of cyclin D1 staining in a mantle cell lymphoma. Immunohistochemical staining of cyclin D1 antibodies is used to diagnose mantle cell lymphoma. Cyclin D1 has been found to be overexpressed in breast carcinoma. Its potential use as a biomarker was suggested.
Background References
1. Totta, P. et al. 2015. Clathrin heavy chain interacts with estrogen receptor α and modulates 17β-estradiol signaling. Molecular endocrinology (Baltimore, Md.). : me20141385.
2. Luo, Y. et al. 2015. Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 36: 2937-45.
Sequence Similarity
Belongs to the cyclin family. Cyclin D subfamily.
Post-translational Modification
Phosphorylation at Thr-286 by MAP kinases is required for ubiquitination and degradation following DNA damage. It probably plays an essential role for recognition by the FBXO31 component of SCF (SKP1-cullin-F-box) protein ligase complex.; Ubiquitinated, primarily as 'Lys-48'-linked polyubiquitination. Ubiquitinated by a SCF (SKP1-CUL1-F-box protein) ubiquitin-protein ligase complex containing FBXO4 and CRYAB. Following DNA damage it is ubiquitinated by some SCF (SKP1-cullin-F-box) protein ligase complex containing FBXO31. SCF-type ubiquitination is dependent on Thr-286 phosphorylation (By similarity). Ubiquitinated also by UHRF2 apparently in a phosphorylation-independent manner. Ubiquitination leads to its degradation and G1 arrest. Deubiquitinated by USP2; leading to its stabilization.
Subcellular Location
Cytoplasm, Nucleus, Membrane, Mitochondrion
Synonyms
AI327039 antibody
B cell CLL/lymphoma 1 antibody
B cell leukemia 1 antibody
B cell lymphoma 1 protein antibody
B-cell lymphoma 1 protein antibody
BCL 1 antibody
BCL-1 antibody
BCL-1 oncogene antibody
BCL1 antibody
BCL1 oncogene antibody
ExpandAI327039 antibody
B cell CLL/lymphoma 1 antibody
B cell leukemia 1 antibody
B cell lymphoma 1 protein antibody
B-cell lymphoma 1 protein antibody
BCL 1 antibody
BCL-1 antibody
BCL-1 oncogene antibody
BCL1 antibody
BCL1 oncogene antibody
ccnd1 antibody
cyclind1 antibody
CCND1/FSTL3 fusion gene, included antibody
CCND1/IGHG1 fusion gene, included antibody
CCND1/IGLC1 fusion gene, included antibody
CCND1/PTH fusion gene, included antibody
CCND1_HUMAN antibody
cD1 antibody
Cyl 1 antibody
D11S287E antibody
G1/S specific cyclin D1 antibody
G1/S-specific cyclin-D1 antibody
Parathyroid adenomatosis 1 antibody
PRAD1 antibody
PRAD1 oncogene antibody
U21B31 antibody
CollapseImages
-
☑ Relative expression (RE)
Western blot analysis of Cyclin D1 on different lysates with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/5,000 dilution and competitor's antibody at 1/5,000 dilution.
Lane 1: MCF7 cell lysate
Lane 2: K-562 cell lysate (negative)
Lane 3: A431 cell lysate
Lane 4: Neuro-2a cell lysate
Lane 5: NIH/3T3 cell lysate
Lane 6: C6 cell lysate
Lane 7: SH-SY5Y cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 34 kDa
Observed band size: 35 kDa
Exposure time: 20 seconds; ECL: K1802;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1601-31) at 1/5,000 dilution and competitor's antibody at 1/5,000 dilution were used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Knockdown (KD)
Western blot analysis of Cyclin D1 on different lysates with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/5,000 dilution.
Lane 1: MCF7-si NT cell lysate
Lane 2: MCF7-si Cyclin D1 cell lysate
Lysates/proteins at 10 µg/Lane.
Predicted band size: 34 kDa
Observed band size: 34 kDa
Exposure time: 17 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1601-31) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of Neuro-2a cells labeling Cyclin D1 with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/2,000 dilution and competitor's antibody at 1/1,600 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/2,000 dilution and competitor's antibody at 1/1,600 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of MCF7 cells labeling Cyclin D1.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1601-31, red) at 1/5,000 dilution and competitor's antibody (red) at 1/2,000 dilution, compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
Immunohistochemical analysis of paraffin-embedded human colon cancer tissue with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/1,000 dilution.
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins. The section was incubated with ET1601-31 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-Cyclin D1 antibody. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-31, 1/200) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue using anti-Cyclin D1 antibody. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-31, 1/200) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded human small intestine tissue using anti-Cyclin D1 antibody. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-31, 1/200) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue using anti-Cyclin D1 antibody. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-31, 1/200) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded mouse stomach tissue with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-31) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat esophagus tissue with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1601-31) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Application: IF-Tissue
Species: Human
Site: colon cancer
Sample: Paraffin-embedded section
Antibody concentration: 1/500 -
☑ Relative expression (RE)
Immunocytochemistry analysis of SH-SY5Y (positive) and 293T (negative) labeling Cyclin D1 with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/2,000 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/2,000 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C6 cells labeling Cyclin D1 with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/2,000 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Cyclin D1 antibody (ET1601-31) at 1/2,000 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Cyclin D1 was immunoprecipitated from 0.2 mg MCF7 cell lysate with ET1601-31 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using ET1601-31 at 1/1,000 dilution. Anti-Rabbit IgG for IP Nano-secondary antibody (NBI01H) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: MCF7 cell lysate (input)
Lane 2: ET1601-31 IP in MCF7 cell lysate
Lane 3: Rabbit IgG instead of ET1601-31 in MCF7 cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 5 seconds; ECL: K1802 -
Immunohistochemical analysis of paraffin embedded human colon cancer tissue using anti-Cyclin D1 antibody (1/1,000) performed on the Leica® BOND™ RX.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Spatial omics study reveals molecular-cellular dynamics of tumor ecosystem in esophageal squamous-cell carcinoma initiation and progression
Journal: Cell Reports Medicine
DOI: 10.1016/j.xcrm.2026.102650
IF: 10.6
Application: mIF
Reactivity: Human
Publish date: 2026 Mar
-
EP300/NCOA1 complex drives glioma angiogenesis via H3K27 acetylation–dependent activation of VEGFA
Journal: Experimental Cell Research
DOI: 10.1016/j.yexcr.2026.115004
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2026 Mar
-
PRR11 as a newly identified oncogenic driver in retinoblastoma
Journal: Science China-Life Sciences
DOI: 10.1007/s11427-025-3094-0
IF: 9.5
Application: WB,IHC
Reactivity: Mouse,Human
Publish date: 2026 Jan
-
Zinc-Induced PKCδ-dependent Phosphorylation of MTF-1 Promotes Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension
Journal: International Journal Of Biological Sciences
DOI: 10.7150/ijbs.124664
IF: 10
Application: WB
Reactivity: Mouse,Rat
Publish date: 2026 Jan
-
Effect of the antifungal drug ciclopirox on the inhibition of HMGA2-mediated oncogenic capacity in ACHN renal cell carcinoma
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2026.1723954
IF: 4.8
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
Oncogenic LPCAT1 Accelerates Intrahepatic Cholangiocarcinoma Development Through PI3K/Akt Signaling-Dependent Cell Cycle Regulation
Journal: Journal Of Gastroenterology And Hepatology
DOI: 10.1111/jgh.70291
IF: 3.4
Application: WB
Reactivity: Mouse,Human
Publish date: 2026 Feb
-
Hydroalcoholic gel of Angelica sinensis polysaccharides promotes wound healing by suppressing ferroptosis through PI3K/AKT/Nrf2 signaling pathway
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2026.157962
IF: 8.3
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
Rebamipide Induces Hair Regeneration Through EP4-Driven Lipid Metabolism Remodeling
Journal: International Journal Of Molecular Sciences
DOI: 10.3390/ijms262010132
IF: 4.9
Application: WB
Reactivity: Mouse
Publish date: 2025 Oct
-
Artemisinin-hydroxychloroquine combination from traditional antimalarial medicine attenuates pulmonary fibrosis via PI3K/AKT/GSK3β-mediated inhibition of epithelial-mesenchymal transition
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.120717
IF: 5.4
Application: WB
Reactivity: Human
Publish date: 2025 Oct
-
Ginsenoside Rb1 Alleviates Atherosclerosis by Modulating Vascular Smooth Muscle Cell Proliferation, Foam Cell Formation, and Autophagy
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2025.157503
IF: 8.3
Application: WB
Reactivity: Mouse
Publish date: 2025 Nov
-
Ethanol Extract of Adlay Hulls Suppresses Acute Myeloid Leukemia Cell Proliferation via PI3K/Akt Pathway Inhibition
Journal: Current Issues In Molecular Biology
DOI: 10.3390/cimb47050358
IF: 2.8
Application: WB
Reactivity: Human
Publish date: 2025 May
-
Forsythoside B suppresses glioblastoma by upregulating the expression of PTPRN
Journal: Neuropharmacology
DOI: 10.1016/j.neuropharm.2025.110514
IF: 4.6
Application: WB
Reactivity: Human,Rat
Publish date: 2025 May
-
SOX4 as a Key Oncogene Driving Tumor Invasion in Retinoblastoma
Journal: Investigative Ophthalmology & Visual Science
DOI: 10.1167/iovs.66.5.24
IF: 4.7
Application: WB,IHC
Reactivity: Human
Publish date: 2025 May
-
Targeting NEDD8 in pediatric acute myeloid leukemia: an integrated bioinformatics and experimental approach
Journal: Hematology
DOI: 10.1080/16078454.2025.2478650
IF: 2
Application: WB
Reactivity: Human
Publish date: 2025 Mar
-
Evaluation of Genipin-Crosslinked Small Intestinal Submucosa for a Full-Thickness Gastric Defect Repair
Journal: JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
DOI: 10.1002/jbm.a.37899
IF: 3.9
Application: WB
Reactivity: Rat
Publish date: 2025 Mar
-
Hypoxia Promotes the In Vitro Proliferation of Buffalo Spermatogonial Cells by Increasing Lactate and H3K18la Lactylation Levels
Journal: Cells
DOI: 10.3390/cells14110832
IF: 5.2
Application: WB
Reactivity: Bovine
Publish date: 2025 Jun
-
SOX3 facilitates granulosa cell proliferation and suppresses cell apoptosis through modulating PI3K/AKT pathway by targeting SPP1
Journal: Cellular And Molecular Life Sciences
DOI: 10.1007/s00018-025-05797-4
IF: 6.2
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Experimental validation, molecular docking, proteomic analysis and network pharmacology reveal Morroniside promoting neurogenesis and improving cognitive impairment via Notch1/Hes1 pathway in intracerebroventricular-streptozotocin mice
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.120322
IF: 5.4
Application: WB
Reactivity: Mouse
Publish date: 2025 Jul
-
Targeting DKC1/NF-κB axis suppresses tumorigenesis and enhances 5-FU sensitivity in gastric cancer
Journal: Cancer Cell International
DOI: 10.1186/s12935-025-03926-4
IF: 6
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
SIRT3 mediates Tubeimoside I’s inhibition on pulmonary artery smooth muscle cell proliferation and oxidative stress in pulmonary arterial hypertension
Journal: European Journal Of Pharmacology
DOI: 10.1016/j.ejphar.2025.177938
IF: 4.7
Application: WB
Reactivity: Rat
Publish date: 2025 Jul
-
Smoking promotes the progression of bladder cancer through FOXM1/CKAP2L axis
Journal: Journal Of Translational Medicine
DOI: 10.1186/s12967-025-06835-2
IF: 7.5
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
KDM6B enhances anti-PD-L1 immunotherapy efficacy by increasing CD8+ T-cell infiltration in colorectal cancer
Journal: Journal Of Cancer
DOI: 10.7150/jca.118571
IF: 3.2
Application: WB
Reactivity: Human,Mouse
Publish date: 2025 Jul
-
Mannose-Modified Multifunctional Iron-Based Nanozyme for Hepatocellular Carcinoma Treatment by Remodeling the Tumor Microenvironment
Journal: Colloids And Surfaces B: Biointerfaces
DOI: 10.1016/j.colsurfb.2025.114548
IF: 5.4
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
Ependymal Yes-Associated Protein Promotes the Neural Regeneration Through Enhancing the Ependymal Cell-Derived Perilesional Glial Borders in Mice After Spinal Cord Injury
Journal: Acta Physiologica
DOI: 10.1111/apha.70147
IF: 5.6
Application: WB
Reactivity: Mouse
Publish date: 2025 Dec
-
Embryonic exposure to Smoothened Agonist disrupts tongue development in mice
Journal: Developmental Biology
DOI: 10.1016/j.ydbio.2025.04.018
IF: 2.5
Application: IHC-P
Reactivity: Mouse
Publish date: 2025 Apr
-
Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer
Journal: Journal Of Medicinal Chemistry
DOI:
IF: 6.8
Application: WB
Reactivity: Human
Publish date: 2024 Sep
-
Reduced Proline-Rich Tyrosine Kinase 2 Promotes Tumor Metastasis by Activating Epithelial–Mesenchymal Transition in Colorectal Cancer
Journal: Digestive Diseases And Sciences
DOI:
IF: 2.5
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
Hydrochlorothiazide disrupts DNA damage response to exacerbate skin photosensitivity
Journal: Ecotoxicology And Environmental Safety
DOI:
IF: 6.2
Application: WB
Reactivity: Human
Publish date: 2024 Nov
-
IPCEF1: Expression Patterns, Clinical Correlates and New Target of Papillary Thyroid Carcinoma
Journal: Journal Of Cancer
DOI:
IF: 3.3
Application: WB
Reactivity: Human
Publish date: 2024 Nov
-
4-hydroxysesamin protects rat with right ventricular failure due to pulmonary hypertension by inhibiting JNK/p38 MAPK signaling
Journal: Aging-Us
DOI: 10.18632/aging.205808
IF: 3.9
Application: WB
Reactivity: Rat
Publish date: 2024 May
-
Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma via RAB7B-mediated autophagy
Journal: Toxicology And Applied Pharmacology
DOI:
IF: 3.8
Application: WB
Reactivity: Mouse
Publish date: 2024 Mar
-
Columbianadin suppresses glioblastoma progression by inhibiting the PI3K-Akt signaling pathway
Journal: Biochemical Pharmacology
DOI:
IF: 5.8
Application: WB
Reactivity: Mouse
Publish date: 2024 Mar
-
Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma
Journal: Translational Lung Cancer Research
DOI: 10.21037/tlcr-24-344
IF: 4
Application: WB
Reactivity: Human
Publish date: 2024 Jun
-
Traditional Medicine Xianglian Pill Suppresses high-fat diet-related colorectal cancer via inactivating TLR4/MyD88 by remodeling gut microbiota composition and bile acid metabolism
Journal: Journal Of Ethnopharmacology
DOI:
IF: 5.4
Application:
Reactivity: Human
Publish date: 2024 Jun
-
PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway
Journal: Translational Lung Cancer Research
DOI: 10.21037/tlcr-24-340
IF: 4
Application: WB
Reactivity: Human
Publish date: 2024 Jun
-
Production of recombinant human epidermal growth factor fused with HaloTag protein and characterisation of its biological functions
Journal: Peer J
DOI:
IF: 2.3
Application: WB
Reactivity: Human
Publish date: 2024 Jul
-
Tenacissoside H repressed the progression of glioblastoma by inhibiting the PI3K/Akt/mTOR signaling pathway
Journal: European Journal Of Pharmacology
DOI:
IF: 5
Application: WB
Reactivity: Mouse
Publish date: 2024 Feb
-
Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivo
Journal: European Journal Of Medicinal Chemistry
DOI: 10.1016/j.ejmech.2024.116209
IF: 6
Application: WB
Reactivity: Human
Publish date: 2024 Feb
-
BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β
Journal: Cell Death Discovery
DOI:
IF: 6.1
Application: WB
Reactivity: Human
Publish date: 2024 Feb
-
Integrating network pharmacology, molecular docking and experimental verification to reveal the mechanism of artesunate in inhibiting choroidal melanoma
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2024.1448381
IF: 4.4
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
Arsenic-induced downregulation of BRWD3 suppresses proliferation and induces apoptosis in lung adenocarcinoma cells through the p53 and p65 pathways
Journal: Human & Experimental Toxicology
DOI:
IF: 2.7
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
RGS1 targeted by miR-191-3p inhibited the stemness properties of esophageal cancer cells by suppressing CXCR4/PI3K/AKT signaling
Journal: Acta Histochemica
DOI: 10.1016/j.acthis.2024.152190
IF: 2.3
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
Sophocarpine inhibits the progression of glioblastoma via PTEN/PI3K/Akt signaling pathway
Journal: American Journal Of Cancer Research
DOI: 10.62347/SQJB1901
IF: 3.6
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
Evodiamine Inhibits the Progression of Esophageal Aquamous Cell Carcinoma via Modulating PI3K/AKT/mTOR Pathway
Journal: Preprint And Has Not Been Certified By Peer Review
DOI: 10.21203/rs.3.rs-4133300/v1
IF:
Application: WB
Reactivity: Human,Mouse
Publish date: 2024 Apr
-
LTBP2 regulates cisplatin resistance in GC cells via activation of the NF-κB2/BCL3 pathway
Journal: Genetics And Molecular Biology
DOI:
IF: 1.7
Application: WB
Reactivity: Human
Publish date: 2024 Apr
-
3 β-Hydroxy-12-oleanen-27-oic Acid Exerts an Antiproliferative Effect on Human Colon Carcinoma HCT116 Cells via Targeting FDFT1
Journal: International Journal Of Molecular Sciences
DOI:
IF: 5.6
Application: WB
Reactivity: Mouse
Publish date: 2023 Oct
-
Angelicin impedes the progression of glioblastoma via inactivation of YAP signaling pathway
Journal: Biomedicine & Pharmacotherapy
DOI:
IF: 7.5
Application: WB
Reactivity: Rat
Publish date: 2023 May
-
TPP1 inhibits DNA damage response and chemosensitivity in esophageal cancer
Journal: Critical Reviews In Eukaryotic Gene Expression
DOI:
IF: 1.6
Application: WB
Reactivity: Human
Publish date: 2023 May
-
ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma
Journal: BMC Cancer
DOI:
IF: 4.638
Application: WB
Reactivity: Human
Publish date: 2023 May
-
Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway
Journal: Biochemical And Biophysical Research Communications
DOI:
IF: 3.1
Application: WB
Reactivity: Human
Publish date: 2023 Jan
-
SUMOylation of AnxA6 facilitates EGFR-PKCα complex formation to suppress epithelial cancer growth
Journal: Cell Communication And Signaling
DOI:
IF:
Application: WB
Reactivity: Human
Publish date: 2023 Aug
-
AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression
Journal: Oncogene
DOI:
IF: 8
Application: WB
Reactivity: Mouse,Human
Publish date: 2023 Aug
-
Anti-diabetic drug canagliflozin hinders skeletal muscle regeneration in mice
Journal: Acta Pharmacologica Sinica
DOI:
IF: 8.2
Application: WB
Reactivity: Mouse
Publish date: 2022 Oct
-
Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling
Journal: Frontiers In Pharmacology
DOI:
IF: 5.988
Application: WB
Reactivity: Human
Publish date: 2022 Nov
-
Cholesterol Sulfate Exerts Protective Effect on Pancreatic β-Cells by Regulating β-Cell Mass and Insulin Secretion
Journal: Frontiers In Pharmacology
DOI:
IF: 4.4
Application: WB
Reactivity: Mouse
Publish date: 2022 Mar
-
ACY-1215 suppresses the proliferation and induces apoptosis of chronic myeloid leukemia cells via the ROS/PTEN/Akt pathway
Journal: Cell Stress & Chaperones
DOI:
IF: 3.827
Application: WB
Reactivity: Human
Publish date: 2022 Jun
-
Autophagy participates in germline cyst breakdown and follicular formation by modulating glycolysis switch via Akt signaling in newly-hatched chicken ovaries
Journal: Developmental Biology
DOI:
IF: 2.7
Application: WB
Reactivity: Chicken
Publish date: 2022 Jul
-
Role of oncogene PIM-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress. Molecular and cellular endocrinology, 523, 111144.
Journal: Molecular And Cellular Endocrinology
DOI:
IF: 4.102
Application: WB
Reactivity: Human
Publish date: 2021 Mar
-
Proteasome regulation by reversible tyrosine phosphorylation at the membrane
Journal: Oncogene
DOI:
IF: 9.867
Application: WB
Reactivity: Human
Publish date: 2021 Mar
-
A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer. Cell death & disease, 12(7), 683.
Journal: Cell Death & Disease
DOI:
IF: 8.469
Application: WB
Reactivity: Mouse
Publish date: 2021 Jul
-
All-Trans Retinoic Acid Potentiates Antitumor Efficacy of Cisplatin by Increasing Differentiation of Cancer Stem-Like Cells in Cervical Cancer. Annals of clinical and laboratory science, 51(1), 22–29.
Journal: Annals Of Clinical And Laboratory Science
DOI:
IF:
Application: WB
Reactivity: Human
Publish date: 2021 Jan
-
Inhibition of cyclooxygenase-2 enhanced intestinal epithelial homeostasis via suppressing β-catenin signalling pathway in experimental liver fibrosis
Journal: Journal Of Cellular And Molecular Medicine
DOI:
IF: 4.48
Application: WB,IHC-P
Reactivity: Mouse
Publish date: 2021 Aug
-
Canagliflozin impairs blood reperfusion of ischaemic lower limb partially by inhibiting the retention and paracrine function of bone marrow derived mesenchymal stem cells
Journal: eBioMedicine
DOI:
IF: 6.68
Application: WB
Reactivity: Mouse
Publish date: 2020 Feb
-
Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β-catenin pathway
Journal: Oncology Reports
DOI:
IF: 3.041
Application: WB
Reactivity: Human
Publish date: 2019 Dec
Products with the same target and pathway
Cyclin D1 Rabbit Polyclonal Antibody
Application: WB,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Cyclin D1 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse,Rat,Zebrafish
Conjugate: unconjugated
Cyclin D1 Recombinant Rabbit Monoclonal Antibody [PD01-64]
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated